Related Experiment Videos
Reduction of error rates in the microlymphocytotoxicity test
Abstract:
The overall error rate of the microlymphocytotoxicity test has been reduced from 1.08% in 1971 to approximately 0.35%, based on comparisons of 882 replicate test pairs (different bleedings) and on family studies, with 0.11% attributable to "reading" errors. This reduction was attributed to automation for lymphocyte adding, better incubation temperature control, better technical preparation of cells and stronger, more monospecific sera. Three types of errors contribute to the overall error rate: random, sera-related (affected by strength and specificity), and lymphocyte-related (possible B-cell reactivity and donor/lymphocyte physiological condition). Strongly skewed error distributions, which seem to be lymphocyte-related, occurred in less than 4% of the test pairs.
Insights
The microlymphocytotoxicity test error rate significantly decreased from 1.08% to 0.35% due to automation and improved reagents. This enhances the reliability of this crucial diagnostic test.
Area of Science:
- Immunology
- Clinical Diagnostics
Background:
- The microlymphocytotoxicity test is a critical method for HLA typing and antibody screening.
- Historically, the test has faced challenges with a notable overall error rate impacting diagnostic accuracy.
Purpose of the Study:
- To analyze the reduction in the overall error rate of the microlymphocytotoxicity test.
- To identify the contributing factors and types of errors in the test.
Main Methods:
- Analysis of 882 replicate test pairs and family studies to assess error rates.
- Comparison of error rates from 1971 to the present, correlating with technical advancements.
Main Results:
- The overall error rate decreased from 1.08% in 1971 to approximately 0.35%.
- Reading errors account for 0.11% of the total error rate.
- Improvements in automation, incubation control, cell preparation, and serum quality were key factors.
- Random, sera-related, and lymphocyte-related errors were identified, with lymphocyte-related issues in less than 4% of tests.
Conclusions:
- Significant improvements in methodology have drastically reduced microlymphocytotoxicity test errors.
- Automation and enhanced reagent specificity are crucial for improving test reliability.
- Understanding error sources allows for continued refinement of diagnostic immunology techniques.